Definium Therapeutics DFTX Cash Flow Statement (2021-2026)

NASDAQ DFTX
$38.09 +0.09 (+0.24%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Definium Therapeutics Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Definium Therapeutics reported cash from operations of -$52.78M and free cash flow of -$52.91M for the quarter ended Jun 2026, down 78.3% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-17.20M1.79M-18.50M-16.96M-16.48M2.06M-19.58M-27.87M-20.45M-21.30M-20.98M-21.81M-22.01M-29.84M-30.33M-40.47M-44.71M-45.37M-57.01M-72.72M
Share-based Compensation
4.11M4.34M3.79M4.25M4.29M1.38M3.75M3.84M4.23M3.37M3.69M5.43M3.84M3.95M3.43M5.25M5.82M5.60M11.48M9.64M
Gains from Investment Securities
5.18M1.50M-3.02M2.96M32.89M-13.45M-8.36M4.85M-7.00M2.23M22.55M5.06M20.05M86.23M
Cash from Operations
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.33M-13.85M-16.63M-20.56M-16.60M-19.99M-17.19M-25.35M-29.42M-29.60M-29.57M-42.98M-42.63M-52.78M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
2.42M-0.14M-0.46M-0.59M1.36M
Amortization of Deferred Charges
0.04M0.04M
Change in Working Capital
Change in Account Payables
0.69M0.65M-0.84M-2.59M0.10M1.27M0.21M6.26M-0.93M-3.51M1.51M-2.96M-0.53M-0.14M0.26M1.95M3.90M-2.77M1.78M-0.16M
Change in Accured Expenses
-5.47M7.52M0.99M-0.20M-0.17M-1.04M0.70M3.19M-0.15M1.58M-2.70M0.99M1.03M3.79M-1.33M3.01M3.36M0.92M2.99M6.85M
Other Working Capital Changes
-0.87M3.09M-0.92M0.38M-1.30M2.10M-0.91M-0.11M-0.56M1.54M-0.47M1.49M-0.49M3.81M1.38M-3.12M-0.85M2.44M-0.58M0.26M
Investing Activities
Capital Expenditures
-0.02M-0.02M-0.03M0.01M-0.07M-0.02M-0.03M0.07M0.01M-0.01M-0.01M-0.02M-0.12M0.13M
Acquisitions
Change in Acquisitions & Divestments
33.75M42.00M41.00M42.00M39.00M
Cash from Investing Activities
-0.03M0.11M-162.46M-39.54M15.41M34.98M42.00M-316.74M
Financing Activities
Other financing activities
0.51M-0.01M0.12M0.58M17.04M0.04M1.70M2.73M245.57M0.58M0.42M257.85M3.83M801.17M
Change in Capital Stock
Net Equity Issued and Repurchased
-0.00M27.50M0.73M0.58M1.30M3.10M2.59M
Misc.
Cash from Financing Activities
0.82M0.13M-0.17M0.59M58.21M0.42M0.58M1.27M17.40M2.59M169.25M10.79M69.35M3.81M1.00M19.65M0.75M245.87M5.31M762.27M
Exchange Rate Effect
4.81M-4.79M-0.04M-0.19M-0.14M0.06M0.01M0.06M0.03M-0.03M-0.02M0.00M-0.01M0.00M-0.01M0.03M-0.02M0.00M0.00M-0.00M
Change in Cash
-11.18M-12.38M-13.07M-14.73M48.78M-12.38M-12.73M-12.51M0.80M-18.00M152.63M-9.20M52.15M-21.54M-190.89M-49.46M-13.43M237.88M4.68M392.75M
Free Cash Flow
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.31M-13.83M-16.60M-20.57M-16.53M-19.96M-17.17M-25.42M-29.43M-29.59M-29.56M-42.96M-42.51M-52.91M
Net Cash Flow
-15.99M-7.59M-13.03M-14.54M48.91M-12.43M-12.75M-12.57M0.77M-17.97M152.65M-9.20M52.16M-21.54M-190.88M-49.49M-13.41M237.88M4.68M392.75M